Diversified Financials Healthcare Sector

Arcturus Therapeutics Holdings

Market Cap: US$330.9m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

iTeos Therapeutics

Market Cap: US$327.6m

A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.

Nano-X Imaging

Market Cap: US$327.4m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

Alpha Teknova

Market Cap: US$319.0m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Outset Medical

Market Cap: US$318.1m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

EBR Systems

Market Cap: AU$493.5m

Develops implantable systems for wireless tissue stimulation.

Cidara Therapeutics

Market Cap: US$314.9m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Varex Imaging

Market Cap: US$312.2m

Designs, manufactures, and sells X-ray imaging components.

Abeona Therapeutics

Market Cap: US$311.6m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

National Research

Market Cap: US$309.7m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

Cytek Biosciences

Market Cap: US$306.5m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

Cryoport

Market Cap: US$302.8m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Aurora Cannabis

Market Cap: CA$413.8m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

XOMA Royalty

Market Cap: US$297.4m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Cresco Labs

Market Cap: CA$404.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

American Oncology Network

Market Cap: US$289.0m

Through its subsidiaries, provides oncology management services in the United States.

Canopy Growth

Market Cap: CA$397.0m

Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Compass Therapeutics

Market Cap: US$289.0m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Imricor Medical Systems

Market Cap: AU$446.6m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Heron Therapeutics

Market Cap: US$282.2m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Phathom Pharmaceuticals

Market Cap: US$280.0m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Pacific Biosciences of California

Market Cap: US$276.6m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Oceania Healthcare

Market Cap: NZ$463.5m

Owns and operates retirement villages and care centres in New Zealand.

Gossamer Bio

Market Cap: US$272.8m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

Tvardi Therapeutics

Market Cap: US$272.3m

Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.

Candel Therapeutics

Market Cap: US$272.1m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Ocugen

Market Cap: US$271.8m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

Sanara MedTech

Market Cap: US$270.1m

A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.

Oncology Institute

Market Cap: US$269.5m

An oncology company, provides various medical oncology services in the United States.

Corvus Pharmaceuticals

Market Cap: US$269.1m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Immutep

Market Cap: AU$416.2m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Alumis

Market Cap: US$265.2m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

Entrada Therapeutics

Market Cap: US$264.4m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Terns Pharmaceuticals

Market Cap: US$263.8m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

NervGen Pharma

Market Cap: CA$362.0m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

Neuronetics

Market Cap: US$262.6m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.